Cell Culture News and Research

RSS

Cell culture is the process of isolating cells from an organism and growing them in a scientifically controlled environment

SARS-CoV-2 rapidly adapts to Vero E6 cell culture propagation

Researchers at the Erasmus Medical Centre in the Netherlands and the University of Illinois at Urbana-Champaign in the US found that SARS-CoV-2 rapidly adapts to Vero E6 cell culture propagation and that this can be prevented by using cell lines with an active serine protease-mediated entry pathway.

26 Jan 2021

Scientists develop a model to track viral load in COVID-19 patients

Scientists from the University of Alberta, Canada, have developed a model to determine patient-specific viral load curves for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The data obtained from this model can be used in other higher-level models to evaluate the physiological and pathological impacts of virus infection and determine patient risks.

25 Jan 2021

Stem cell based cell culture model to recapitulate important aspects of NAFLD

Nonalcoholic fatty liver disease (NAFLD) is a widespread condition in the Western World. Around 30% of the population have lipid droplets stored in their liver which diminish its function in the long term.

25 Jan 2021

Corning to highlight newest products in 3D cell culture portfolio at SLAS2021

Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year's virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27.

22 Jan 2021

Patient-specific model is needed to understand cancer cells and their impacts

Despite cancer being a leading cause of death worldwide, treatment options for many types of cancers remain limited. This is partly due to the in vitro tools used to model cancers, which cannot adequately predict the behavior of a cancer or its sensitivity to drugs.

22 Jan 2021

PromoCell's New GMP Certification - EXCiPACT

In this interview, News-Medical talks to Dr. Irma Börcsök (CEO of PromoCell) and Dörte Keimer (Head of Quality Assurance) about PromoCell, the work they do and the latest GMP certification the company has achieved - EXCiPACT.

From PromoCell 21 Jan 2021

Researchers define tumor invasion machinery orchestrated by a master cancer gene

Researchers investigated how cancer genes lead to the breakdown of the capsule that prevents cancerous cells from invading the surrounding healthy tissues and - find a hijacked "molecular crowbar".

18 Jan 2021

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel.

From Jellagen 15 Jan 2021

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

A new study reports the preclinical testing of a recombinant MVA (rMVA) candidate vaccine against SARS-CoV-2, the agent that is causing the current COVID-19 pandemic.

14 Jan 2021

Could fenofibrate be an effective antiviral against SARS-CoV-2?

The resurgence of COVID-19 pandemic, caused by the SARS-CoV-2, has led to renewed efforts to find effective antivirals, both newly developed or repurposed drugs. A study reports the efficacy of the cholesterol-reducing drug fenofibrate in reducing infection rates of SARS-CoV-2 in cultured cells.

13 Jan 2021

Researchers develop novel antibody fragments against SARS coronavirus-2

An international research team led by the University of Bonn (Germany) has identified and further developed novel antibody fragments against the SARS coronavirus-2. These "nanobodies" are much smaller than the classic antibodies used to treat US President Donald Trump, for example.

13 Jan 2021

Nanobodies have potential to be developed into a treatment for COVID-19

Researchers at Karolinska Institutet in Sweden have developed, in collaboration with researchers in Germany and the U.S., new small antibodies, also known as nanobodies, which prevent the SARS-CoV-2 coronavirus from entering human cells.

12 Jan 2021

Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro

In a recent bioRxiv* preprint paper, researchers from Germany analyzed aqueous licorice root extract for its neutralizing activity against SARS-CoV-2 in vitro. They identified glycyrrhizin, the primary active ingredient in the root, and revealed the underlying mechanism of viral neutralization.

5 Jan 2021

Copper surfaces can inactivate SARS-CoV-2 in as little as one minute, study finds

A new study by researchers at the University of Southampton, UK, has found that SARS-CoV-2 can inactivate on copper surfaces in as little as 1 minute. This is faster than the findings of previous studies in which it took as much as 4 hours before the virus was inactivated.

5 Jan 2021

Scientists design experimental gut-brain system in a lab dish

Research into what is known as the gut-brain axis continues to reveal how the brain and gut influence each other's health and well-being. Now researchers are endeavoring to learn more about gut-brain discourse using a model system built in a lab dish.

4 Jan 2021

Researchers use fruit fly model to understand COVID-19-related neurological complications

Researchers claim to have reproduced disease mechanisms due to coronavirus disease 2019 (COVID-19) in the fruit fly, Drosophila, while also providing proof of the efficacy of one drug against these disease processes. If validated, these findings represent a new understanding of how the virus causes neurological symptoms that could help develop more effective therapies.

23 Dec 2020

Researchers control cardiac waves with light to study abnormally rapid heart rhythms

Over 300,000 people die each year in the U.S. due to sudden cardiac death. In many cases, sudden cardiac death is caused by abnormally rapid heart rhythms called tachycardias, which means the heart cannot pump adequate blood to the body.

22 Dec 2020

Anti-diarrhea drug triggers cell death in glioblastoma cells

In cell culture, loperamide, a drug commonly used against diarrhea, proves effective against glioblastoma cells. A research team at Goethe University has now unraveled the drug’s mechanisms of action of cell death induction and – in doing so – has shown how this compound could help attack brain tumors that otherwise are difficult to treat.

22 Dec 2020

CN Bio and University of Melbourne announce partnership focused on respiratory therapies for recovering COVID-19 patients

CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.

18 Dec 2020

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Application of low-intensity pulsed ultrasound in combination with microbubbles might enhance the delivery of chemotherapy medication used for treating cancers.

17 Dec 2020

Cell Culture News and Research

Further Reading

SARS-CoV-2 rapidly adapts to Vero E6 cell culture propagation

Scientists develop a model to track viral load in COVID-19 patients

Stem cell based cell culture model to recapitulate important aspects of NAFLD

Corning to highlight newest products in 3D cell culture portfolio at SLAS2021

Patient-specific model is needed to understand cancer cells and their impacts

PromoCell's New GMP Certification - EXCiPACT

Researchers define tumor invasion machinery orchestrated by a master cancer gene

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Researchers develop novel antibody fragments against SARS coronavirus-2

Nanobodies have potential to be developed into a treatment for COVID-19

Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro

Copper surfaces can inactivate SARS-CoV-2 in as little as one minute, study finds

Scientists design experimental gut-brain system in a lab dish

Researchers use fruit fly model to understand COVID-19-related neurological complications

Researchers control cardiac waves with light to study abnormally rapid heart rhythms

Anti-diarrhea drug triggers cell death in glioblastoma cells

CN Bio and University of Melbourne announce partnership focused on respiratory therapies for recovering COVID-19 patients

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo